Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 41, Issue 3, 2008, Pages 253-259

  Weber, C ^a   Schaper, J ^a   Tibussek, D ^a   Adams, O ^a   MacKenzie, C R ^a   Dilloo, D ^a   Meisel, R ^a   Gobel U ^a   Laws, H J ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; ETOPOSIDE; LYMPHOCYTE ANTIBODY; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADD ON THERAPY; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLOSIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CODING; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SYMPTOM; TOXICITY; TOXOPLASMOSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; MENINGITIS; NEOPLASM RECURRENCE, LOCAL; NEUROTOXICITY SYNDROMES; RETROSPECTIVE STUDIES; SEIZURES; SURVIVAL ANALYSIS;

EID: 39349095621     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705905     Document Type: Article

References (22)

1. Openshaw H, Slatkin N. Neurological complications. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Oxford, UK, 1999 pp 659-673.
2. Uckan D, Cetin M, Yigitkanli I, Tezcan I, Tuncer M, Karasimav D et al Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant 2005; 35 71-76.
3. Iguchi A, Kobayashi R, Yoshida M, Kaneda M, Watanabe N, Cho Y et al Neurological complications after stem cell transplantation in childhood. Bone Marrow Transplant 1999; 24: 647-652.
4. De Brabander C, Cornelissen J, Smitt PA, Vecht CJ, Van Den Bent MJ. Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 2000; 68: 36-40.
5. Bleggi-Torres LF, De Medeiros BC, Werner B, Neto JZ, Loddo G, Pasquini R et al. Neuropathological findings after bone marrow transplantation: An autopsy study of 180 cases. Bone Marrow Transplant 2000; 25: 301-307.
6. Wiznitzer M, Packer RJ, August CS, Burkey ED. Neurological complications of bone marrow transplantation in childhood. Ann Neurol 1984; 16: 569-576.
7. Burdach S, Van Kaick B, Laws HJ, Ahrens S, Haase R, Korholz D et al A allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St Anna Kinderspital, Vienna, Austria. Ann Oncol 2000; 11: 1451-1462.
8. Schonberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kogler G et al. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: A single centre matched-pair analysis in a heterogeneous risk population. Klin Padiatr 2004; 216: 356-363.
9. Laws HJ, Kobbe G, Dilloo D, Dettenkofer M, Meisel R, Geisel R et al Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients. J Hosp Infect 2006; 62: 80-88.
10. Martin P, Nash R, Sanders J, Leisenring W, Anasetti C, Deeg HJ et al Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant 1998; 21: 273-279.
11. Wong R, Beguelin GZ, De Lima M, Giralt SA, Hosing C, Ippoliti C et al Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 128-134.
12. Blohm ME, Nurnberger W, Aulich A, Engelbrecht V, Burdach S. Reversible brain MRI changes in acyclovir neurotoxicity. Bone Marrow Transplant 1997; 19: 1049-1051.
13. De Medeiros BC, De Medeiros CR, Werner B, Neto JZ, Loddo G, Pasquini R et al. Central nervous system infections following bone marrow transplantation: An autopsy report of 27 cases. J Hematother Stem Cell Res 2000; 9: 535-540.
14. Jantunen E, Volin L, Salonen O, Piilonen A, Parkkah T, Anttila VJ et al. Central nervous system aspergillosis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2003; 31: 191-196.
15. Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000; 31: 1188-1195.
16. Martino R, Cordonnier C. Toxoplasmosis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31: 617-618; author reply 619.
17. Maertens J, Theunissen K, V.erbeken E, Lagrou K, Verhaegen J, Boogaerts M et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004; 126: 852-860.
18. Roemer E, Blau IW, Basara N. Kiehl MG, Bischoff M, Gunzelmann S et al Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: Successful treatment strategies during a 5-year single-center experience. Clin Infect Dis 2001; 32: E1-E8.
19. Tenenbaum T, Kramm CM, Laws HJ, Nurnberger W, Lenard HG, Gobel U. Pre-eruptive varicella zoster virus encephalitis in two children after haematopoietic stem cell transplantation. Med Pediatr Oncol 2002; 38: 289-289.
20. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
21. Furlong T, Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K et al Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. Bone Marrow Transplant 2000; 26: 985-991.
22. Lavenstein B, Stewart C, Tina LU. Cyclosporine-associated encephalopathy in childhood transplant patients. Transplant Proc 1988; 20: 285-287.